ProImmune launches ProVE SL self-loading MHC Class I monomers to improve T cell research flexibility: Oxford, England Saturday, November 1, 2025, 14:00 Hrs [IST] ProImmune Ltd, a ...

Leiden researchers have found clues to why a rare pregnancy disorder is mild in some babies but life-threatening in others.

ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class I Monomers.

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...

A 56-year-old man was admitted to the hospital because of left lower abdominal pain and anemia. He had a 1-year history of ...

Immune checkpoint inhibitors (ICIs) emerged in the US about 15 years ago as an exciting class of cancer treatments that have ...

The Labaid Group is developing AI-based healthtech solutions and plans to establish 30 satellite cancer centres across Bangladesh to usher in a more precise healthcare. In an interview with The ...

Leiden researchers have found clues to why a rare pregnancy disorder is mild in some babies but life-threatening in others. Their discovery opens the ...

Researchers have developed an AI-assisted technology that can identify and tag chromosomal abnormalities in cells.